Abilita Bio

Focused on developing technologies to enable discovery and development of drugs targeting membrane proteins, including GPCRs

placeSan Diego, California, United States calendar_todayFounded 2014 groups13 employees language abilitabio.com

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 365 times.

YearFilings
20161
20172
20182
20192
20201
20211
20242
20252
20261

Investor mix

2 investors on record.

Investor typeCountShare
Other / undisclosed2100%
Coming soon